"Anti-Ulcer Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
| Descriptor ID |
D000897
|
| MeSH Number(s) |
D27.505.954.483.203
|
| Concept/Terms |
Anti-Ulcer Agents- Anti-Ulcer Agents
- Agents, Anti-Ulcer
- Anti Ulcer Agents
- Anti-Ulcer Drugs
- Anti Ulcer Drugs
- Drugs, Anti-Ulcer
|
Below are MeSH descriptors whose meaning is more general than "Anti-Ulcer Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Ulcer Agents".
This graph shows the total number of publications written about "Anti-Ulcer Agents" by people in this website by year, and whether "Anti-Ulcer Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 3 | 3 | 6 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 0 | 2 |
| 1999 | 5 | 0 | 5 |
| 2000 | 3 | 0 | 3 |
| 2001 | 3 | 0 | 3 |
| 2002 | 2 | 1 | 3 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 3 | 5 |
| 2005 | 3 | 2 | 5 |
| 2006 | 3 | 0 | 3 |
| 2008 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Ulcer Agents" by people in Profiles.
-
Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding. Pharmacoeconomics. 2010; 28(3):217-30.
-
Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit. Pharmacotherapy. 2008 Aug; 28(8):968-76.
-
Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008 Jul; 42(6):676-9.
-
Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study. Aliment Pharmacol Ther. 2008 Apr; 27(8):666-77.
-
More than hoarseness: laryngopharyngeal reflux in children. Nursing. 2007 Nov; 37(11):24-5.
-
Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol. 2006 Sep; 101(9):1972-8; quiz 2169.
-
Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006 Aug; 130(2):386-91.
-
Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers. Clin Ther. 2006 May; 28(5):725-33.
-
Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions. Clin Gastroenterol Hepatol. 2005 Dec; 3(12):1207-14.
-
Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin Pharmacother. 2005 Nov; 6(14):2501-10.